OAN Staff Jenna Lee
5:42 PM – Thursday, May 14, 2026
The U.S. Department of Justice (DOJ) has formally accused the Yale School of Medicine of discriminating against White and Asian American applicants. This follows a comprehensive, yearlong investigation launched to ensure the university’s compliance with the 2023 Supreme Court ruling that prohibited race-conscious admissions policies.
According to the DOJ, internal documents and communications obtained during the inquiry reveal that Yale intentionally utilized race as a decisive factor in its selection process, effectively bypassing the Supreme Court’s mandate.
Trending: CIA Furious as Active Agent Testifies on Fauci’s Enormous Role in COVID ‘Cover-Up’
The DOJ’s findings further allege that the medical school’s admissions committee maintained a system that favored Black and Hispanic applicants over those from other backgrounds with comparable or much superior academic credentials. Federal investigators stated that the university’s internal data demonstrated a clear intent to meet specific racial benchmarks rather than adhering to a strictly race-neutral, holistic review.
While Yale University has denied these claims and defended its admissions practices as legally sound, the DOJ asserts that the institution’s reliance on racial preferences violates Title VI of the Civil Rights Act of 1964, which prohibits discrimination on the basis of race, color, or national origin in programs receiving federal financial assistance.
“Yale has continued its race-based admissions program despite the Supreme Court and the public’s clear mandate for reform. This Department will continue to shed light on these illegal practices, and demand that institutions of higher education comply with federal law, said Assistant Attorney General Harmeet K. Dhillon of the DOJ’s Civil Rights Division.
After investigating median grade-point averages and standardized test scores broken down by race, the investigation found that Black applicants had “as much as 29 times higher odds of getting an interview for admission than an equally strong Asian applicant with similar academic credentials.”
“This consistent difference in the test scores between students of different racial groups is substantial and cannot be explained by a coincidence,” the DOJ added.
The recent findings against Yale School of Medicine follow a closely related investigation into the David Geffen School of Medicine at the University of California, Los Angeles, where the DOJ issued similar allegations of discriminatory admissions practices earlier this month.
Meanwhile, these actions represent a coordinated effort by the Trump administration to dismantle racist policies at elite medical institutions. Federal officials contend that these schools have prioritized diversity and social equity “goals” over academic merit and objective standards, thereby violating federal civil rights laws.
As part of this systematic crackdown on unfair social engineering in healthcare education, the DOJ has expanded its scope beyond Yale and UCLA, launching formal probes into the admissions processes at Stanford University, the University of California, San Diego, and Ohio State University.
These investigations aim to determine if these medical schools are utilizing clandestine racial preferences or “proxy” variables to circumvent the Supreme Court’s ban on affirmative action.
Stay informed! Receive breaking news alerts directly to your inbox for free. Subscribe here. https://www.oann.com/alerts
What do YOU think? Click here to jump to the comments!
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!